Sachdev Gitansha Shreyas, Ramamurthy Shreyas, Dandapani Ramamurthy
Refractive Services, The Eye Foundation, Coimbatore, India.
Clin Ophthalmol. 2018 Apr 30;12:783-790. doi: 10.2147/OPTH.S156500. eCollection 2018.
To assess the safety, efficacy, and refractive predictability of half-fluence accelerated corneal collagen crosslinking (CXL) applied concurrently with photorefractive keratectomy (PRK), and compare the results to standard PRK.
Refractive Services, The Eye Foundation, Coimbatore, India.
Interventional comparative case series.
Patients seeking refractive correction for myopia or myopic astigmatism were included in the study. Photorefractive keratectomy with concurrent half-fluence crosslinking (PRK Xtra) was performed in eyes with borderline suspicious tomography (not amounting to forme fruste keratoconus) or low pachymetry between 450 and 474 µm with an otherwise unremarkable corneal tomography. Eyes with normal corneal tomography and thickness between 475 and 500 µm underwent standard PRK. The minimum follow-up period was 1 year.
In total, 109 eyes underwent PRK Xtra (Group A) and 118 eyes underwent PRK alone (Group B). The preoperative MRSE was -3.64 D and -3.38 D in Groups A and B, respectively (=0.28). Group A had a significantly higher number of eyes with thinner corneas (<0.01) and corneal tomographic abnormalities (=0.02). At 1 year follow-up, 96.3% of eyes in group A as against 99.1% of eyes in group B achieved a best corrected distance visual acuity (CDVA) of 20/20 or better. No iatrogenic ectasia or hyperopic shift secondary to progressive flattening was noted in the PRK Xtra group. No significant difference in incidence of haze was noted.
PRK Xtra showed comparable safety, efficacy, and stability to PRK in eyes with thinner pachymetry and tomographic abnormalities. Combining crosslinking with PRK in suspicious tomographies augurs for safe and predictable outcomes.
评估与准分子激光角膜切削术(PRK)同时应用的半能量加速角膜胶原交联(CXL)的安全性、有效性和屈光预测性,并将结果与标准PRK进行比较。
印度哥印拜陀市眼基金会屈光服务中心。
干预性比较病例系列研究。
纳入寻求近视或近视散光屈光矫正的患者。对于角膜地形图临界可疑(未达圆锥角膜forme fruste)或角膜厚度在450至474 µm之间且角膜地形图其他方面无异常的眼睛,进行同时行半能量交联的准分子激光角膜切削术(PRK Xtra)。角膜地形图正常且厚度在475至500 µm之间的眼睛接受标准PRK。最短随访期为1年。
总共109只眼睛接受了PRK Xtra(A组),118只眼睛仅接受了PRK(B组)。A组和B组术前平均等效球镜度分别为-3.64 D和-3.38 D(P = 0.28)。A组角膜较薄(P<0.01)和角膜地形图异常(P = 0.02)的眼睛数量明显更多。在1年随访时,A组96.3%的眼睛与B组99.1%的眼睛达到了最佳矫正远视力(CDVA)20/20或更好。PRK Xtra组未发现医源性扩张或因渐进性扁平导致的远视性移位。在 haze 发生率方面未发现显著差异。
PRK Xtra在角膜厚度较薄和地形图异常的眼睛中显示出与PRK相当的安全性、有效性和稳定性。在可疑地形图中联合交联与PRK可实现安全且可预测的结果。